» Articles » PMID: 28750503

Protein and Vitamin B6 Intake Are Associated with Liver Steatosis Assessed by Transient Elastography, Especially in Obese Individuals

Overview
Specialty Gastroenterology
Date 2017 Jul 29
PMID 28750503
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Although the detrimental effects of several dietary components on the promotion of nonalcoholic fatty liver disease are well known, no studies have assessed the role of dietary vitamin B6. Moreover, studies on the associations between dietary components or body composition indices and liver steatosis assessed by transient elastography are rare. Our aim was to identify the nutritional factors and anthropometric parameters associated with liver steatosis.

Methods: In this cross-sectional study, we enrolled 168 individuals (35% obese) who underwent a liver steatosis assessment by Controlled Attenuation Parameter measurement and nutritional assessment.

Results: Tertiles of vitamin B6 intake were positively associated with hepatic steatosis (B=1.89, =0.026, confidence interval [CI] 0.03-0.80) as well as with triglycerides, glucose, alanine aminotransferase (ALT), and body mass index . In obese individuals, after multivariable analysis, the Controlled Attenuation Parameter score was still associated with triglycerides, ALT, and total protein intake (B=0.56, =0.01, CI 0.10-1.02). Participants in tertile I (low intake) had a lower Controlled Attenuation Parameter than those in tertile III (=0.01).

Conclusions: We found a positive association between hepatic steatosis or Controlled Attenuation Parameter score and vitamin B6/total protein intake, probably related to the high intake of meat. Vitamin B6 might have a pathogenic role related to the increase of hepatic steatosis.

Citing Articles

Supplementation of Micro- and Macronutrients-A Role of Nutritional Status in Non-Alcoholic Fatty Liver Disease.

Tyczynska M, Hunek G, Szczasny M, Brachet A, Januszewski J, Forma A Int J Mol Sci. 2024; 25(9).

PMID: 38732128 PMC: 11085010. DOI: 10.3390/ijms25094916.


Examining the Pathogenesis of MAFLD and the Medicinal Properties of Natural Products from a Metabolic Perspective.

Fu Y, Wang Z, Qin H Metabolites. 2024; 14(4).

PMID: 38668346 PMC: 11052500. DOI: 10.3390/metabo14040218.


Associations between one-carbon metabolism and valproic acid-induced liver dysfunction in epileptic patients.

Zhu J, Wang Z, Sun X, Wang D, Xu X, Yang L Front Pharmacol. 2024; 15:1358262.

PMID: 38464726 PMC: 10924308. DOI: 10.3389/fphar.2024.1358262.


Citrus Bergamia and Cynara Cardunculus Reduce Serum Uric Acid in Individuals with Non-Alcoholic Fatty Liver Disease.

Ferro Y, Maurotti S, Mazza E, Pujia R, Sciacqua A, Musolino V Medicina (Kaunas). 2022; 58(12).

PMID: 36556930 PMC: 9784233. DOI: 10.3390/medicina58121728.


Association between the index of nutritional quality and lipid profile in adult women.

Abbas Torki S, Bahadori E, Shekari S, Fathi S, Gholamalizadeh M, Hasanpour Ardekanizadeh N Endocrinol Diabetes Metab. 2022; 5(5):e358.

PMID: 35856460 PMC: 9471585. DOI: 10.1002/edm2.358.


References
1.
Scorletti E, Byrne C . Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease. Annu Rev Nutr. 2013; 33:231-48. DOI: 10.1146/annurev-nutr-071812-161230. View

2.
Hassan M, Hwang L, Hatten C, Swaim M, Li D, Abbruzzese J . Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002; 36(5):1206-13. DOI: 10.1053/jhep.2002.36780. View

3.
Psaty B, Furberg C, Kuller L, Bild D, Rautaharju P, Polak J . Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: the Cardiovascular Health Study. Arch Intern Med. 1999; 159(12):1339-47. DOI: 10.1001/archinte.159.12.1339. View

4.
Mondul A, Mancina R, Merlo A, Dongiovanni P, Rametta R, Montalcini T . PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity. J Nutr. 2015; 145(8):1687-91. PMC: 4516767. DOI: 10.3945/jn.115.210633. View

5.
Higuchi O, Nakagawa K, Tsuzuki T, Suzuki T, Oikawa S, Miyazawa T . Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 5'-phosphate as the inhibitor. J Lipid Res. 2006; 47(5):964-74. DOI: 10.1194/jlr.M500348-JLR200. View